Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry China, the United States, Europe, and internationally. The company de...
SIRIO: The "Australia YouSiYi" incident is a marketing issue of individual brands and does not involve systemic risks in the production and manufacturing process
Hui Tongxing once promoted fake foreign health products You Siyiyi, customer service responded
SIRIO released its performance for the first three quarters, with a net profit attributable to the parent company of 260 million yuan, an increase of 8.53%
Guangfa Securities: Consumer goods consumers pursue "cost-effectiveness + high value" and are optimistic about the recovery of demand after the clearance of liquor
HuaChuang Securities: Functional foods accelerate penetration, tapping into new opportunities in industry reshaping
SIRIO released its performance for the first half of the year, with a net profit attributable to the parent company of 161 million yuan, a year-on-year increase of 4.30%